N-acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis.
about
A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future PerspectivesNeurofilament in CSF-A biomarker of disease activity and long-term prognosis in multiple sclerosisNeurofilament light chain level is a weak risk factor for the development of MS.Body fluid biomarkers for multiple sclerosis--the long road to clinical application.Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.Endogenous repair and development inspired therapy of neurodegeneration in progressive multiple sclerosis.Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.The developing landscape of diagnostic and prognostic biomarkers for spinal cord injury in cerebrospinal fluid and blood.Effect of carotid endarterectomy on brain damage markers.Fluid biomarker and electrophysiological outcome measures for progressive MS trials.Defining active progressive multiple sclerosis.Any evident MRI T2 lesion activity should guide change of therapy in multiple sclerosis--commentary.Science is 1% inspiration and 99% biomarkers.The best basic science paper in multiple sclerosis in 2014: citicoline, remyelination and neuroprotection: commentary.Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study
P2860
Q28068709-6ED60F27-A973-46F7-8775-40F24355C320Q28276772-4B948993-ACC4-47B2-9D8F-B64360B6636FQ37265143-5E43EFBB-8ECE-4C3E-A318-23375795EC94Q38590773-04A1ECE6-BBBB-440E-87F9-488A997FC0C7Q38682945-E6F00DF0-E95F-4789-850E-B2E329020E98Q38765008-83E2FB31-BAB8-4A42-95A5-88E5A746489FQ38984981-B3999725-FA1C-4E75-8C8A-B73941C097ABQ39044367-476539D2-6D5B-4600-8EB2-528C0A9EE103Q39811657-024D4296-D800-46BB-B0C4-7616EA132EA4Q47638443-452D70D6-B372-4A13-B638-067AE28E7386Q47918387-7FF2EC2B-9964-44E3-99EE-EA741F1B8FBCQ48359316-130D46F4-48D0-48E6-9833-EC8DDB0B8646Q50984144-1A0F4ECC-8A78-4438-BC52-CD855A26B0FFQ53610339-DE7CF879-4148-4BAC-BB58-5164FC12FCC1Q57161829-8B729BC3-3FA5-4751-9BB6-F651F58F76A1
P2860
N-acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
N-acetylaspartate and neurofil ...... e forms of multiple sclerosis.
@en
N-acetylaspartate and neurofil ...... e forms of multiple sclerosis.
@nl
type
label
N-acetylaspartate and neurofil ...... e forms of multiple sclerosis.
@en
N-acetylaspartate and neurofil ...... e forms of multiple sclerosis.
@nl
prefLabel
N-acetylaspartate and neurofil ...... e forms of multiple sclerosis.
@en
N-acetylaspartate and neurofil ...... e forms of multiple sclerosis.
@nl
P2093
P2860
P50
P1433
P1476
N-acetylaspartate and neurofil ...... e forms of multiple sclerosis.
@en
P2093
Alex Rovira
Birthe Roos
Carsten Korth
Joep Killestein
Manuel Comabella
Marleen J A Koel-Simmelink
Philipp Ottis
Xavier Montalban
P2860
P2888
P304
P356
10.1007/S00415-014-7507-4
P577
2014-09-17T00:00:00Z